Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study to Compare Three Different Formulations of Tenofovir 1% Gel When Administered Rectally

This study has been completed.
Sponsor:
Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)
CONRAD
Information provided by (Responsible Party):
Ian McGowan, University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT01575405
First received: February 29, 2012
Last updated: November 6, 2013
Last verified: November 2013